This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MILTON M. CAHN, M.D.; Edwin J. LEVY, M.D.

AMA Arch Derm. 1957;75(1):38-40.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Abnormal skin reactions to sunlight have been reported occasionally among patients receiving chlorpromazine^* therapy. Since this abnormal photosensitivity is a transient involvement, it appears that some factor in sunlight, present only at certain times, is responsible for triggering the eruption. In an attempt to determine what the critical light factor may be, the following study was undertaken.

Method

Ten patients were studied from a group of 105 receiving chlorpromazine therapy for various neuropsychiatric disorders at the Sidney Hillman Medical Center, Philadelphia.⁶ Five of these patients developed sunlight-induced erythematopapular eruptions with pruritus, although they had no previous histories of abnormal photosensitivity. None of these five patients had received medication other than chlorpromazine prior to the onset of the skin reactions. The other five patients had no side-effects to chlorpromazine nor had they histories of dermatitis. In addition, five volunteers who had neither received chlorpromazine nor had . . . [Full Text PDF of this Article]

Author Affiliations
Philadelphia

From the Department of Dermatology (Dr. Donald M. Pillsbury, Director), University of Pennsylvania, School of Medicine.

Footnotes
Submitted for publication Feb. 23, 1956.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?